Patent details

Basic Information

Publication number:

EP2971094

PCT Application Number:

US2014024128

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147179220

PCT Publication Number:

WO2014150751

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BIOMARKERS ASSOCIATED WITH BRM INHIBITION

French Title of Invention:

BIOMARQUEURS ASSOCIÉS À L'INHIBITION DE BRM

German Title of Invention:

BIOMARKER IM ZUSAMMENHANG MIT BRM-HEMMUNG

SPC Number:

Dates

Filing date:

12/03/2014

Grant date:

15/09/2021

EP Publication Date:

20/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/09/2021

EP B1 Publication Date:

15/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/03/2022

Expiration date:

12/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/09/2021

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

MICKANIN, Craig

Address:

United States (US)

2

Name:

HOFFMAN, Gregory

Address:

United States (US)

3

Name:

JAGANI, Zainab

Address:

United States (US)

4

Name:

STEGMEIER, Frank

Address:

United States (US)

Priority

1

Priority Number:

201361791945 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

2

Priority Number:

201361846178 P

Priority Date:

15/07/2013

Priority Country:

United States (US)

Classification

IPC classification:

C12Q 1/68;

Publication

European Patent Bulletin

Issue number:

202137

Publication date:

15/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages